Orticumab Antibody
Orticumab (MLDL1278A) is a recombinant human monoclonal antibody targeting oxidized LDL (oxLDL) . It modulates autoimmune responses to oxLDL, showing therapeutic potential for atherosclerosis by improving plaque pathology and for autoimmune conditions like psoriasis, as supported by in vivo and in vitro research.
Product Specifications
Product Name Alternative
MLDL1278A
Target
LDLR, LDL
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Metabolism Research
Concentration
20.297 mg/mL
Purity
≥95% (May vary between batches)
Molecular Weight
~150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog